Avience Biomedicals Ltd - IPO

Avience Biomedicals Ltd IPO Details

Initial public offer of up to 16,08,000 equity shares of face value of Rs. 10/- each (The Equity Shares) of Avience Biomedicals Limited (The Company or ABL or The Issuer) at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores (Public Issue) out of which 80,400 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (The Market Maker Reservation Portion). The public issue less market maker reservation portion i.e. issue of 15,27,600 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating upto Rs. [*] crores is herein after referred to as the Net Issue. The public issue and net issue will constitute [*] and [*] % respectively of the post-issue paid-up equity share capital of the company.The price band and the minimum bid lot will be decided by the company.

Objective of issue

Capital expenditure towards setting up of a new mfg unit at. Funding the working capital requirements of the company. General corporate purposes.

Avience Biomedicals Ltd Contact Details

Avience Biomedicals Ltd, D-153/A 1st Flr, Okhla Industrial Are, Phase-I, New Delhi-110020

Phone - 011 - 26812682 / 83

Fax - 011 - 26812682

Email - info@avienbio.com

Website - www.avienbio.com